相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Advances in histone demethylase KDM4 as cancer therapeutic targets
Dong Hoon Lee et al.
FASEB JOURNAL (2020)
Time-Varying Pattern of Mortality and Recurrence from Papillary Thyroid Cancer: Lessons from a Long-Term Follow-Up
Wenwu Dong et al.
THYROID (2019)
Radioiodine-Refractory Thyroid Cancer: Molecular Basis of Redifferentiation Therapies, Management, and Novel Therapies
Mohamed Aashiq et al.
CANCERS (2019)
Congenital goitrous hypothyroidism is caused by dysfunction of the iodide transporter SLC26A7
Jun Ishii et al.
COMMUNICATIONS BIOLOGY (2019)
Wnt/β-Catenin Pathway Activation Mediates Adaptive Resistance to BRAF Inhibition in Colorectal Cancer
Guangming Chen et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Molecular Analysis of Congenital Hypothyroidism in Saudi Arabia: SLC26A7 Mutation Is a Novel Defect in Thyroid Dyshormonogenesis
Minjing Zou et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Wnt Signaling in Thyroid Homeostasis and Carcinogenesis
Kim A. Ely et al.
GENES (2018)
Homozygous loss-of-function mutations in SLC26A7 cause goitrous congenital hypothyroidism
Hakan Cangul et al.
JCI INSIGHT (2018)
Identification and characterization of PKF118-310 as a KDM4A inhibitor
Gianluigi Franci et al.
EPIGENETICS (2017)
Roles of Wnt Target Genes in the Journey of Cancer Stem Cells
Jee-Heun Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor
Shan Zeng et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Cyp24a1 Attenuation Limits Progression of BrafV600E-Induced Papillary Thyroid Cancer Cells and Sensitizes Them to BRAFV600E Inhibitor PLX4720
Minjing Zou et al.
CANCER RESEARCH (2017)
TSH overcomes BrafV600E-induced senescence to promote tumor progression via downregulation of p53 expression in papillary thyroid cancer
M. Zou et al.
ONCOGENE (2016)
Recent incidences and differential trends of thyroid cancer in the USA
Yushan Mao et al.
ENDOCRINE-RELATED CANCER (2016)
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
Inigo Lancia et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
β-catenin signaling is required for RAS-driven thyroid cancer through PI3K activation
Ana Sastre-Perona et al.
ONCOTARGET (2016)
Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer
Mingzhao Xing et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Anoctamin-1/TMEM16A is the major apical iodide channel of the thyrocyte
L. Twyffels et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2014)
Wnt some lose some: transcriptional governance of stem cells by Wnt/β-catenin signaling
Wen-Hui Lien et al.
GENES & DEVELOPMENT (2014)
Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer
Mingzhao Xing et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up
Raymon H. Grogan et al.
SURGERY (2013)
Molecular pathogenesis and mechanisms of thyroid cancer
Mingzhao Xing
NATURE REVIEWS CANCER (2013)
The many faces and functions of β-catenin
Tomas Valenta et al.
EMBO JOURNAL (2012)
Small Molecule Antagonists of the Wnt/Beta-Catenin Signaling Pathway Target Breast Tumor-Initiating Cells in a Her2/Neu Mouse Model of Breast Cancer
Robin M. Hallett et al.
PLOS ONE (2012)
Wnt/β-Catenin and MAPK Signaling: Allies and Enemies in Different Battlefields
Daniele Guardavaccaro et al.
SCIENCE SIGNALING (2012)
Wnt/β-Catenin Signaling and AXIN1 Regulate Apoptosis Triggered by Inhibition of the Mutant Kinase BRAFV600E in Human Melanoma
Travis L. Biechele et al.
SCIENCE SIGNALING (2012)
Ras Stabilization Through Aberrant Activation of Wnt/β-Catenin Signaling Promotes Intestinal Tumorigenesis
Woo-Jeong Jeong et al.
SCIENCE SIGNALING (2012)
β-Catenin Signaling Controls Metastasis in Braf-Activated Pten-Deficient Melanomas
William E. Damsky et al.
CANCER CELL (2011)
Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling
J. A. Knauf et al.
ONCOGENE (2011)
Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/β-catenin antagonists against human osteosarcoma cells
Pay-Chin Leow et al.
INVESTIGATIONAL NEW DRUGS (2010)
The β-Catenin Axis Integrates Multiple Signals Downstream from RET/Papillary Thyroid Carcinoma Leading to Cell Proliferation
Maria Domenica Castellone et al.
CANCER RESEARCH (2009)
The BRAFV600E Oncogene Induces Transforming Growth Factor β Secretion Leading to Sodium Iodide Symporter Repression and Increased Malignancy in Thyroid Cancer
Garcilaso Riesco-Eizaguirre et al.
CANCER RESEARCH (2009)
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
Bryan T. MacDonald et al.
DEVELOPMENTAL CELL (2009)
Minireview: The Sodium-Iodide Symporter NIS and Pendrin in Iodide Homeostasis of the Thyroid
Aigerim Bizhanova et al.
ENDOCRINOLOGY (2009)
BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer
Cristina Romei et al.
ENDOCRINE-RELATED CANCER (2008)
Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers
Zhi Liu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
James Tsai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Snail family transcription factors are implicated in thyroid carcinogenesis
Robert G. Hardy et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism
C. Durante et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Suppression of BRAF/MEK/MAP kinase pathway restores expression of iodide-metabolizing genes in thyroid cells expressing the V600E BRAF mutant
Dingxie Liu et al.
CLINICAL CANCER RESEARCH (2007)
Wnt/β-catenin signaling in development and disease
Hans Clevers
CELL (2006)
The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3
Paul A. C. Cloos et al.
NATURE (2006)
Expression of endogenous oncogenic V600EB-raf induces proliferation and developmental defects in mice and transformation of primary fibroblasts
K Mercer et al.
CANCER RESEARCH (2005)
Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation
JA Knauf et al.
CANCER RESEARCH (2005)
Functional characterization of pendrin in a polarized cell system - Evidence for pendrin-mediated apical iodide efflux
MP Gillam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
β-catenin expression in thyroid follicular lesions:: Potential role in nuclear envelope changes in papillary carcinomas
S Rezk et al.
ENDOCRINE PATHOLOGY (2004)
Thyrocyte-specific expression of Cre recombinase in transgenic mice
T Kusakabe et al.
GENESIS (2004)
β-Catenin dysregulation in thyroid neoplasms -: Down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis
G Garcia-Rostan et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
分享论文
